THE SUBTYPE-2 (AT(2)) ANGIOTENSIN RECEPTOR REGULATES RENAL CYCLIC GUANOSINE 3',5'-MONOPHOSPHATE AND AT(1) RECEPTOR-MEDIATED PROSTAGLANDIN E(2) PRODUCTION IN CONSCIOUS RATS

Citation
Hm. Siragy et Rm. Carey, THE SUBTYPE-2 (AT(2)) ANGIOTENSIN RECEPTOR REGULATES RENAL CYCLIC GUANOSINE 3',5'-MONOPHOSPHATE AND AT(1) RECEPTOR-MEDIATED PROSTAGLANDIN E(2) PRODUCTION IN CONSCIOUS RATS, The Journal of clinical investigation, 97(8), 1996, pp. 1978-1982
Citations number
24
Categorie Soggetti
Medicine, Research & Experimental
ISSN journal
00219738
Volume
97
Issue
8
Year of publication
1996
Pages
1978 - 1982
Database
ISI
SICI code
0021-9738(1996)97:8<1978:TS(ARR>2.0.ZU;2-G
Abstract
The renal effects of angiotensin II(AII) are attributed to AT(1) recep tors. In contrast, the function of renal AT(2) receptorsis unknown. Us ing a microdialysis technique, we monitored changes in renal interstit ial fluid (RIF) prostaglandin E(2) (PGE(2)) and cyclic guanosine 3',5' -monophosphate (cGMP) in response to dietary sodium (Na) depletion alo ne, or Na depletion or normal Na diet combined with the AT(1) receptor blocker, Losartan, the AT(2) receptor blocker, PD 123319 (PD), or ang iotensin II, individually or combined in conscious rats, Na depletion significantly increased PGE(2) and cGMP, During Na depletion, Losartan decreased PGE(2) and did not change cGMP. In contrast, PD significant ly increased PGE(2) and decreased cGMP, Combined administration of Los artan and PD decreased PGE(2) and cGMP. During normal Na diet, RIF PGE (2) and cGMP increased in response to angiotensin II, Neither Losartan nor PD, individually or combined, changed RIF PGE(2) or cGMP. Combine d administration of angiotensin II and Losartan or PD produced a signi ficant decrease in response of PGE(2) and cGMP to angiotensin II, resp ectively, These data demonstrate that activation of the renin-angioten sin system during Na depletion increases renal interstitial PGE(2) and cGMP, The AT(1) receptor mediates renal production of PGE(2). The AT( 2) receptor mediates cGMP. AT(2) blockade potentiates angiotensin-indu ced PGE(2) production at the AT(1) receptor.